BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12796525)

  • 1. L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism.
    Kaiser R; Hofer A; Grapengiesser A; Gasser T; Kupsch A; Roots I; Brockmöller J
    Neurology; 2003 Jun; 60(11):1750-5. PubMed ID: 12796525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
    Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
    J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
    Purcaro C; Vanacore N; Moret F; Di Battista ME; Rubino A; Pierandrei S; Lucarelli M; Meco G; Fattapposta F; Pascale E
    Neurosci Lett; 2019 Jan; 690():83-88. PubMed ID: 30316985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.
    Contin M; Martinelli P; Mochi M; Albani F; Riva R; Scaglione C; Dondi M; Fanti S; Pettinato C; Baruzzi A
    Clin Neuropharmacol; 2004; 27(3):111-5. PubMed ID: 15190232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease.
    Dos Santos EUD; Sampaio TF; Tenório Dos Santos AD; Bezerra Leite FC; da Silva RC; Crovella S; Asano AGC; Asano NMJ; de Souza PRE
    J Pharm Pharmacol; 2019 Feb; 71(2):206-212. PubMed ID: 30353564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.
    Oliveri RL; Annesi G; Zappia M; Civitelli D; Montesanti R; Branca D; Nicoletti G; Spadafora P; Pasqua AA; Cittadella R; Andreoli V; Gambardella A; Aguglia U; Quattrone A
    Neurology; 1999 Oct; 53(7):1425-30. PubMed ID: 10534246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
    Guttman M; Stewart D; Hussey D; Wilson A; Houle S; Kish S
    Neurology; 2001 Jun; 56(11):1559-64. PubMed ID: 11402115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.
    Hurley MJ; Mash DC; Jenner P
    Eur J Neurosci; 2003 Nov; 18(9):2668-72. PubMed ID: 14622169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients.
    Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ
    J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F
    Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
    Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
    Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
    Koprich JB; Huot P; Fox SH; Jarvie K; Lang AE; Seeman P; Brotchie JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():151-6. PubMed ID: 23306217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease.
    Higuchi S; Muramatsu T; Arai H; Hayashida M; Sasaki H; Trojanowski JQ
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):107-13. PubMed ID: 9620058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.
    Juyal RC; Das M; Punia S; Behari M; Nainwal G; Singh S; Swaminath PV; Govindappa ST; Jayaram S; Muthane UB; Thelma BK
    Neurogenetics; 2006 Nov; 7(4):223-9. PubMed ID: 16816977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
    Strong JA; Dalvi A; Revilla FJ; Sahay A; Samaha FJ; Welge JA; Gong J; Gartner M; Yue X; Yu L
    Mov Disord; 2006 May; 21(5):654-9. PubMed ID: 16435402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
    Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
    Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.
    Güzey C; Scordo MG; Spina E; Landsem VM; Spigset O
    Eur J Clin Pharmacol; 2007 Mar; 63(3):233-41. PubMed ID: 17225991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.